

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
I-Ivacaftor iyimithi eyingqayizivele eyenzelwe ukwelapha i-cystic fibrosis kubantu abanezinguquko ezithile zofuzo. Le mithi yomlomo isebenza ngokuthi isize amaprotheni anezinkinga emangqamuzaneni akho ukuthi asebenze kangcono, okungathuthukisa kakhulu ukusebenza kwamaphaphu kanye nekhwalithi yempilo iyonke. Iyingxenye yesizukulwane esisha semithi eqondile eqondise imbangela eyinhloko ye-cystic fibrosis kunokuthi imane ilawule izimpawu.
I-Ivacaftor iyimithi kadokotela eqondisa ngqo imbangela eyinhloko ye-cystic fibrosis ezingeni lamaselula. Ngokungafani nokwelashwa kwendabuko okugxila ekulawuleni amafinyila nezifo, le mithi empeleni isiza ukulungisa iziteshi zamaprotheni ezingalungile emangqamuzaneni akho abangela lesi sifo.
Le mithi ingeyeqembu elibizwa ngokuthi ama-CFTR potentiators, okusho ukuthi ithuthukisa ukusebenza kwephrotheni ye-CFTR. Cabanga ngayo njengokusiza ukuvula iminyango emangqamuzaneni akho avaleke, okuvumela usawoti namanzi ukuthi ahambe ngokujwayelekile ezicutshini zomzimba wakho.
I-Ivacaftor isebenza kuphela kubantu abanezinguquko ezithile zofuzo ze-cystic fibrosis, ikakhulukazi uguquko lwe-G551D nezinye izinguquko eziningana zokuvula. Udokotela wakho uzodinga ukuqinisekisa uhlobo lwakho oluthile lofuzo ngokuhlolwa ngaphambi kokunikeza le mithi.
I-Ivacaftor isetshenziswa ikakhulukazi ukwelapha i-cystic fibrosis ezigulini ezinoguquko oluthile lofuzo oluthinta ukuthi iphrotheni yazo ye-CFTR isebenza kanjani. Le mithi ivunyelwe abantu abanezinguquko zokuvula, ezimele cishe u-4-5% wazo zonke iziguli ze-cystic fibrosis.
Le mithi isiza ukuthuthukisa izici eziningana ezibalulekile zokuphathwa kwe-cystic fibrosis. Ingathuthukisa ukusebenza kwamaphaphu ngokunciphisa amafinyila aqinile, anamathelayo avame ukuvala imigudu yomoya. Iziguli eziningi zithola izifo zokuphefumula ezimbalwa nokuphefumula okuthuthukisiwe emasontweni ambalwa ngemuva kokuqala ukwelashwa.
Ngaphandle kwezinzuzo zokuphefumula, i-ivacaftor ingasiza futhi ngezinkinga zokugaya ezihlobene ne-cystic fibrosis. Umuthi ungathuthukisa ukusebenza kwamanyikwe futhi unciphise ezinye izimpawu zesisu, nakuba ukugxila okuyinhloko kuhlala empilweni yamaphaphu.
I-Ivacaftor isebenza ngokugxila ngqo kuphrotheni ye-CFTR eneziphene, okuyenza ibe umuthi onamandla aphakathi nendawo onesenzo esiqondile kakhulu. Umuthi empeleni usebenza njengokhiye osiza ukuvula iziteshi zamaprotheni emangqamuzeni akho okungenzeka ukuthi ngaphandle kwalokho ahlale evalekile ngenxa yokuguqulwa kwezakhi zofuzo.
Lapho lezi ziteshi zamaprotheni zisebenza kahle, usawoti namanzi angahamba ngendlela ejwayelekile ngaphesheya kwamalunga amangqamuzana. Lokhu kuhamba okuthuthukisiwe kusiza ukudala amafinyila amancane, angabambeki emathunjini akho nakwezinye izitho, okwenza kube lula ukususa izithako ngokwemvelo.
Imiphumela yomuthi iyaqhubeka kunokuba isheshe. Ngenkathi ezinye iziguli zibona ngcono phakathi namasonto ambalwa, izinzuzo eziphelele zivame ukuthuthuka phakathi nezinyanga ezimbalwa zokusetshenziswa okuqhubekayo. Umuthi udinga ukuthathwa njalo ukuze kugcinwe imiphumela yawo yokwelapha.
I-Ivacaftor kufanele ithathwe ngendlela eqondile njengoba kunqunywe udokotela wakho, ngokuvamile kabili ngosuku cishe ngamahora ayi-12 ahlukene. Umuthi usebenza kahle kakhulu uma uthathwa nokudla okunamafutha, njengoba lokhu kuthuthukisa kakhulu ukuthi umzimba wakho uwumunca kahle kangakanani umuthi.
Ukukhetha okuhle kokudla kufaka ubisi lonke, ushizi, ibhotela, ibhotela lamantongomane, amaqanda, noma ukudla okuphekwe ngamafutha. Hlela ukudla noma ukudla okulula okuqukethe okungenani amagremu angama-20 amafutha lapho uthatha umthamo ngamunye. Lokhu akuyona nje isiphakamiso - ukuthatha i-ivacaftor ngaphandle kwamafutha kunganciphisa ukusebenza kwayo ngamaphesenti angama-60%.
Zama ukuthatha imithamo yakho ngesikhathi esifanayo nsuku zonke ukuze ugcine amazinga aqhubekayo ohlelweni lwakho. Uma unenkinga yokukhumbula, setha ama-alamu ocingo noma xhuma imithamo yakho nezikhathi zokudla ezijwayelekile. Ukuqina kusiza ukuqinisekisa ukuthi umuthi usebenza ngempumelelo ngangokunokwenzeka.
I-Ivacaftor ngokuvamile yindlela yokwelapha yesikhathi eside okuzodingeka ukuthi abantu abaningi baqhubeke nayo unomphela. Umuthi awelaphi i-cystic fibrosis, kodwa kunalokho usiza ukuphatha ukungasebenzi kahle kwamaprotheni okubangela lesi sifo.
Udokotela wakho uzoqapha inqubekela phambili yakho ngokusebenzisa izivivinyo zomsebenzi wamaphaphu njalo, ngokuvamile njalo emavikini angu-3-6 ekuqaleni. Lezi zivivinyo zisiza ukuthola ukuthi umuthi usebenza kahle kangakanani nokuthi ngabe kudingeka yini ukulungiswa komthamo. Iningi leziguli ezisabela kahle ku-ivacaftor liqhubeka nokuyithatha iminyaka eminingi.
Abanye abantu bangase badinge ukuyeka okwesikhashana uma bethola imiphumela ethile engemihle noma ukusebenzisana neminye imithi. Kodwa-ke, ukuyeka i-ivacaftor ngokuvamile kusho ukuthi izimpawu ze-cystic fibrosis zizobuyela kancane kancane emazingeni azo angaphambilini. Ungalokothi uyeke ukuthatha lo muthi ngaphandle kokuxoxa nethimba lakho lezempilo kuqala.
Abantu abaningi bayamukela kahle i-ivacaftor, kodwa njengayo yonke imithi, ingabangela imiphumela engemihle esukela kokuncane kuya kokukhulu. Ukuqonda okulindelekile kungakusiza ukuthi uzizwe ulungiseleleke kangcono futhi wazi ukuthi ungaxhumana nini nodokotela wakho.
Imiphumela engemihle ejwayelekile abantu abaningi abayitholayo ihlanganisa:
Le miphumela engemihle ejwayelekile ivamise ukuba mnene futhi ivame ukuthuthuka njengoba umzimba wakho ujwayela umuthi emasontweni ambalwa okuqala kokwelashwa.
Imiphumela engemihle engavamile kodwa ebucayi idinga ukunakekelwa kwezokwelapha ngokushesha. Lezi zimpawu ezikhathazayo zihlanganisa:
Lezi zimpawu zingase zikhombe izinkinga zesibindi, ezenzeka ngezikhathi ezithile kodwa zidinga ukuhlolwa ngokushesha. Udokotela wakho uzoqapha ukusebenza kwesibindi sakho ngezivivinyo zegazi ezivamile ukuze abambe noma yiziphi izinkinga zisasekuqaleni.
I-Ivacaftor ayifanele wonke umuntu one-cystic fibrosis, futhi izici eziningana zingenza lo muthi ungafaneleki noma uyingozi kubantu abathile. Udokotela wakho uzoqapha ngokucophelela umlando wakho wezokwelapha kanye nesimo sakho sempilo yamanje ngaphambi kokuwunika.
Abantu okufanele bagweme i-ivacaftor bahlanganisa labo abanezifo zesibindi ezinzima noma ama-enzyme esibindi aphakanyiswe kakhulu. Umuthi ucutshungulwa yisibindi, ngakho izinkinga zesibindi ezikhona zingase zibe zimbi ngokwelashwa. Udokotela wakho uzohlola ukusebenza kwesibindi sakho ngaphambi kokuqala umuthi.
Imithi ethile ingase isebenzisane ngendlela eyingozi ne-ivacaftor, ikakhulukazi ama-antibiotics athile, ama-antifungals, kanye nemithi yokulwa nokuthuthumela. Hlala utshela udokotela wakho ngayo yonke imithi kadokotela, imithi etholakala ngaphandle kwemvume kadokotela, kanye nezithasiselo ozithathayo. Ezinye izinhlanganisela zingase zidinge ukulungiswa kwemithamo noma ezinye izindlela zokwelapha.
Abesifazane abakhulelwe nabancelisa ibele kufanele baxoxe ngobungozi nezinzuzo ngokucophelela nethimba labo lezempilo. Ngenkathi izifundo zezilwane zingakhombisanga ukulimala, kunemininingwane elinganiselwe ngokuqina kwe-ivacaftor ngesikhathi sokukhulelwa nokuncelisa ibele.
I-Ivacaftor ivame ukutholakala ngaphansi kwegama lomkhiqizo elithi Kalydeco, elikhiqizwa yi-Vertex Pharmaceuticals. Le yifomula yokuqala eyathola ukugunyazwa yi-FDA futhi iseyinguqulo eningi ebekwe ngayo.
Ungase futhi uhlangane ne-ivacaftor njengengxenye yemithi ehlanganisiwe efana ne-Orkambi (ivacaftor/lumacaftor) noma i-Symdeko (ivacaftor/tezacaftor). Lezi zinhlanganisela zenzelwe ukuguqulwa kwezakhi zofuzo okuhlukene futhi ziqukethe i-ivacaftor kanye nezinye izithako ezisebenzayo.
Izinhlobo ezivamile ze-ivacaftor azikatholakali okwamanje, okusho ukuthi i-Kalydeco kanye nemikhiqizo ehlanganisiwe okwamanje yizona kuphela izinketho. Umuthi uvame ukuza ngesimo samaphilisi, nakuba izindlela eziwuketshezi zingase zitholakale ezigulini ezisencane.
Ezinye izindlela zokwelapha ze-ivacaftor zincike kakhulu ekuguqukeni kwakho okuthile kwezakhi zofuzo kanye nesimo sempilo yakho esiphelele. Ezigulini ezinokuguquka okuhlukile kwe-cystic fibrosis, ezinye izinto eziguqula i-CFTR njengokuhlanganiswa kwe-lumacaftor/ivacaftor noma imithi emisha efana ne-elexacaftor/tezacaftor/ivacaftor ingase ifaneleke kakhulu.
Ukwelashwa kwendabuko kwe-cystic fibrosis kuhlala kubalulekile ngisho nasezigulini ezithatha i-ivacaftor. Lokhu kuhlanganisa izindlela zokususa umoya, imithi ephefumulwayo efana ne-dornase alfa, kanye nezithasiselo ze-enzyme ye-pancreatic. Iziguli eziningi ziqhubeka nalezi zindlela zokwelapha kanye ne-ivacaftor ukuze kulawulwe ngokugcwele.
Ezigulini ezingakwazi ukuthatha i-ivacaftor noma ezingenawo ukuguquka kwezakhi zofuzo okulungile, ukwelashwa okugxile ezimpawini kuba indlela eyinhloko. Lokhu kungase kuhlanganise ama-bronchodilators, ama-mucolytics, imithi elwa nokuvuvukala, kanye nokwelashwa okunobudlova kokutheleleka kwamaphaphu.
I-Ivacaftor ne-lumacaftor zisebenza ngendlela ehlukile futhi zivame ukusetshenziswa ndawonye kunokuba zibe ezinye izindlela zokuncintisana. I-Ivacaftor iyi-potentiator esiza amaprotheni e-CFTR akhona ukuthi asebenze kangcono, kuyilapho i-lumacaftor iyi-corrector esiza ukuhambisa amaprotheni amaningi e-CFTR ebusweni beseli.
Ezigulini ezinokuguquka kwe-gating njenge-G551D, i-ivacaftor yodwa ivame ukusebenza kahle kakhulu futhi iyindlela yokwelapha ekhethwayo. Lezi ziguli zivame ukubona ukuthuthuka okukhulu ekusebenzeni kwamaphaphu nasempilweni yonke nge-ivacaftor monotherapy.
Kubantu abanezinguquko ezivamile ze-F508del, inhlanganisela ye-lumacaftor kanye ne-ivacaftor (Orkambi) ivamise ukudingeka. Akukho emithini yomibili eyedwa enikeza inzuzo eyanele kulaba bantu, kodwa uma ihlangene inganikeza ukuthuthuka okukhulu ekusebenzeni kwamaphaphu kanye nekhwalithi yempilo.
Ukukhetha phakathi kwale mithi kuncike ngokuphelele emiphumeleni yakho yokuhlolwa kwezakhi zofuzo. Udokotela wakho uzoqoka ukuthi iyiphi indlela engcono kakhulu ngokusekelwe ezinguqulweni zakho ezithile nokuthi umzimba wakho usabela kanjani ekwelashweni.
I-Ivacaftor ingasetshenziswa ngokuphepha kubantu abanesifo sikashukela, kodwa idinga ukuqapha ngokucophelela nokuxhumana phakathi kweqembu lakho le-cystic fibrosis kanye nabanakekeli besifo sikashukela. Umuthi awuthinti ngqo amazinga kashukela egazini, kodwa ezinye iziguli zibika izinguquko ezidingweni zazo zokuphatha isifo sikashukela.
Abanye abantu abane-cystic fibrosis-related diabetes bathola ukuthi ukulawulwa kukashukela wabo egazini kuthuthuka ku-ivacaftor, mhlawumbe ngenxa yokusebenza okungcono kwamanyikwe. Kodwa-ke, abanye bangase badinge ukulungiswa emithini yabo yesifo sikashukela. Ukuqapha njalo amazinga kashukela egazini kubaluleke kakhulu lapho uqala i-ivacaftor.
Uma ngengozi uphuza i-ivacaftor eningi kunaleyo ebekiwe, xhumana nodokotela wakho noma isikhungo sokulawula ubuthi ngokushesha, ngisho noma uzizwa kahle. Ukuphuza okuningi kungakhuphula ingozi yakho yemiphumela emibi, ikakhulukazi izinkinga zesibindi nokuxhumana kwemithi.
Ungazami ukwenza ngaphezu kwe-overdose ngokweqa umthamo wakho olandelayo. Kunalokho, buyela esimisweni sakho esijwayelekile sokulinganisa njengoba kuqondiswe ngumhlinzeki wakho wokunakekelwa kwezempilo. Gcina umkhondo wokuthi ungakanani umuthi owengeziwe owuphuze nini, njengoba lolu lwazi luzosiza ochwepheshe bezokwelapha ukuthi baqoke inkambo engcono kakhulu yesenzo.
Uma uphuthelwa umthamo we-ivacaftor, yithathe ngokushesha nje lapho ukhumbula, kodwa kuphela uma kungaphakathi kwamahora angu-6 esikhathi sakho esihleliwe. Uma sekudlule amahora angaphezu kwangu-6, weqa umthamo ophuthelwe bese uthatha umthamo wakho olandelayo ngesikhathi esijwayelekile ngokudla okunamafutha.
Ungalokothi uthathe imithamo emibili ngesikhathi esisodwa ukuze ulungise umthamo ophuthelwe, njengoba lokhu kungakhuphula ingozi yakho yemiphumela emibi. Uma uvame ukukhohlwa imithamo, cabangela ukusetha ama-alamu ocingweni noma ukusebenzisa umhleli wamaphilisi ukusiza ukugcina isimiso sakho.
Kufanele uyeke kuphela ukuthatha i-ivacaftor ngaphansi kokuqondiswa kwezokwelapha okuqondile, njengoba ukuyeka imithi ngokuvamile kuholela ekubuyeni kancane kancane kwezimpawu ze-cystic fibrosis. Iziguli eziningi zidinga ukuqhubeka nokuthatha i-ivacaftor unomphela ukuze zigcine izinzuzo zayo.
Udokotela wakho angase ancome ukuyeka okwesikhashana uma uba nemiphumela emibi engathi sína, udinga ukuhlinzwa, noma unezinkinga ezinkulu zemithi. Kodwa-ke, lawa maphutha ngokuvamile asesikhashana, futhi iziguli eziningi zingaqala kabusha ukwelashwa uma inkinga isixazululiwe.
Yebo, i-ivacaftor ngokuvamile isetshenziswa kanye nezinye izindlela zokwelapha i-cystic fibrosis kunokuthi izithathele yona ngokuphelele. Iziguli eziningi ziqhubeka nemikhuba yazo yokuhlanza umoya, imithi ephefumulwayo, kanye nezithasiselo ze-enzyme ngenkathi zithatha i-ivacaftor.
Noma kunjalo, ezinye izinkinga zemithi kungenzeka, ikakhulukazi ngama-antibiotics athile nama-antifungals avame ukusetshenziswa ekunakekelweni kwe-cystic fibrosis. Njalo yazisa bonke abahlinzeki bakho bezempilo ukuthi uthatha i-ivacaftor, futhi ungalokothi uqale imithi emisha ngaphandle kokuhlola ukuthi akukho yini ukuxhumana kuqala.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.